Planet Labs shares are higher today as the market trades into a near-term, company-specific technical catalyst: the scheduled redemption of all outstanding public warrants on April 27, 2026 for $0.01 per warrant. With the stock far above the $11.50 exercise price, warrant holders are incentivized to exercise ahead of the deadline, and equity traders often reposition around these events because they can temporarily affect supply/demand dynamics and perceived dilution.

The company has called the public warrants for redemption, with the redemption date set for April 27, 2026. Any warrants not exercised by that deadline are redeemed for $0.01, effectively forcing holders to decide whether to convert into common shares at the stated exercise price or take the nominal payout. Into the final days before redemption, the stock can see incremental demand from hedging and positioning tied to warrant conversion flows.

Beyond the warrant-related flow, the trade is supported by the narrative established during the company’s latest reported fiscal year: Planet delivered FY2026 revenue of $307.7 million and reported backlog above $900 million, while guiding to FY2027 revenue of $415 million to $440 million. Investors have also emphasized the company’s growing defense and intelligence exposure and high recurring annual contract value as key supports for the rerating.

Near-term, the main variable is whether warrant exercises meaningfully increase share count into the April 27 deadline and how quickly the market digests that supply. After the redemption passes, traders will likely look for clearer signals from new contract announcements and any updates to revenue/EBITDA trajectory that can validate the post-rally valuation, with the next catalyst window centered on upcoming SEC filings and the next earnings cycle.